These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10947451)

  • 1. Bladder cancer markers. Current availability and the future standard of care.
    Sawczuk IS; Burchardt T; Shabsigh A; de la Taille A; Burchardt M
    MLO Med Lab Obs; 2000 Mar; 32(3):30-3, 36, 38 passim; quiz 42-4. PubMed ID: 10947451
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology and staging of bladder cancer.
    Bane BL; Rao JY; Hemstreet GP
    Semin Oncol; 1996 Oct; 23(5):546-70. PubMed ID: 8893867
    [No Abstract]   [Full Text] [Related]  

  • 3. [Definition of specific protein patterns for advanced (metastatic) urinary bladder tumors for individual prognosis determination and treatment choice].
    Junker K; Pilchowski R; Stöhr R; von Eggeling F; Schubert J; Hartmann A
    Urologe A; 2007 Sep; 46(9):1288. PubMed ID: 17593341
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological markers in the diagnosis of recurrent bladder cancer: an overview.
    Mohammed A; Khan Z; Zamora I; Bhatti A
    Expert Rev Mol Diagn; 2008 Jan; 8(1):63-72. PubMed ID: 18088231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular markers for bladder cancer: the road to a multimarker approach.
    Birkhahn M; Mitra AP; Cote RJ
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1717-27. PubMed ID: 18062746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-cell carcinoma of the urinary bladder: diagnosis and management.
    Pan CX; Zhang H; Lara PN; Cheng L
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1707-13. PubMed ID: 17181484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder Cancer: current status of diagnosis & treatment.
    Stanisic TH
    Ariz Med; 1979 Jan; 36(1):34-7. PubMed ID: 420581
    [No Abstract]   [Full Text] [Related]  

  • 8. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer markers.
    Klotz LH
    Can J Urol; 2004 Dec; 11(6):2426. PubMed ID: 15636667
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current status of diagnosis and therapy of bladder carcinoma].
    Matz M
    Z Arztl Fortbild (Jena); 1982 Sep; 76(18):815-21. PubMed ID: 6184893
    [No Abstract]   [Full Text] [Related]  

  • 11. Nomograms for bladder cancer.
    Shariat SF; Margulis V; Lotan Y; Montorsi F; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):41-53. PubMed ID: 18207314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and monitoring for bladder cancer: refining the use of NMP22.
    Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD
    J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular staging of bladder cancer.
    Mitra AP; Datar RH; Cote RJ
    BJU Int; 2005 Jul; 96(1):7-12. PubMed ID: 15963111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of seven screening methods in the diagnosis of bladder cancer.
    Sun Y; He DL; Ma Q; Wan XY; Zhu GD; Li L; Luo Y; He H; Yang L
    Chin Med J (Engl); 2006 Nov; 119(21):1763-71. PubMed ID: 17097029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.
    Lotan Y; Roehrborn CG
    J Urol; 2002 Jan; 167(1):75-9. PubMed ID: 11743279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary bladder tumor markers.
    Lokeshwar VB; Selzer MG
    Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bibliography. Current world literature. Oncology: bladder and testis.
    Curr Opin Urol; 2000 Sep; 10(5):528-37. PubMed ID: 11005457
    [No Abstract]   [Full Text] [Related]  

  • 18. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder cancer.
    Glashan RW
    Practitioner; 1982 Nov; 226(1373):1891-8. PubMed ID: 7156011
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathology of bladder cancer: An update on selected issues.
    Pavone-Macaluso M; Lopez-Beltran A; Aragona F; Bassi P; Fitzpatrick JM
    BJU Int; 2006 Dec; 98(6):1161-5. PubMed ID: 16879435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.